The brown snakes (genus Pseudonaja) are considered to be the most dangerous group of snakes in Australia, causing up to 60070 of deaths from snake envenomation'. There are at least eight species, the most notorious being the common brown snake (P. textilis) which has the second most toxic venom in the world 2 • In the majority of brown snake envenomations the species is unidentified', but envenomations for P. textilis, P. nucha/is and P. affinis has been documented in humans 2 • 3 and studied in dogs·· 5 , and are known to be highly dangerous. Fatal brown snake envenomation may still occur despite the use of antivenom 6 • Little information is available about the toxic effects of the other five species of brown snake which are all considered possibly dangerous to man'.
Ingram's Brown Snake (P. ingramt) is a rare species found only in the Barkley Tablelands (Northern Territory and Queensland) and in an isolated pocket 300 km to the south s . To our knowledge little is known of the venom of this snake' and there have been no previous documented envenomations in humans.
CASE REPORT
A fit 25-year-old male snake handler was bitten on the left middle finger by a captive Ingram's Brown Snake during routine cage maintenance. He had a history of three previous snake bites: a death adder in 1984 requiring antivenom; a tiger snake in 1986 and a northern death adder in 1990. The snake responsible was obtained from a new site 300 km south of the Barkley Tablelands in Western Queensland. It had a spinal deformity believed to be due to exposure to extremely high temperatures prior to hatching and was only 75 cm in lengths. After being bitten the patient reflexly flicked the snake onto the floor, sucked the bite site and quickly recaptured the snake. He then felt suddenly nauseated and generally unwell with a severe headache, although these symptoms improved on lying flat. A compression bandage was subsequently applied and the arm immobilized.
On arrival in hospital thirty minutes later, he had neurological symptoms with photophobia, irritability, nausea and headache. His vital signs were stable and a 12-lead ECG was normal with no conduction defects. A swab of the bite site was positive to ELISA brown snake venom assay. He had a coagulopathy consistent with disseminated intravascular coagulation (DIC) ( Table 1 ) and received 4 x 1000 units of brown snake anti venom over fourteen hours before his coagulation profile returned to normal. With each dose of antivenom he received adrenaline 0.3 mg subcutaneously and promethazine 50 mg IV. In addition he was given hydrocortisone 200 mg IV with the second dose. With the fourth dose of promethazine he developed a dystonic reaction which was treated with midazolam and chlorpromazine.
He also had a mild thrombocytopenia (lowest 112 x 10 9 /1) which persisted for several days. Some tenderness around the umbilicus was noted and a large haematoma developed at a venupuncture site in the antecubital fossa. Urinalysis revealed microscopic haematuria, but there was no myoglobinuria or myoglobinaemia. Six hours after envenomation, the patient had an isolated episode of haemoptysis and an epistaxis which lasted thirty minutes. His haemoglobin, however, only dropped from 147 to 125 g/l. Fresh frozen plasma was not given. He had a raised lactate dehydrogenase and direct bilirubin levels suggesting a degree of intravascular haemolysis. The patient also developed mild renal impairment, despite adequate fluid replacement and urine output, which returned to normal over three days (maximum creatinine 0.16 mmolll). Neurologic symptoms resolved shortly after the first dose of anti venom and within fifteen hours the patient was asymptomatic. There were no further sequelae.
DISCUSSION
Ingram's Brown Snake (named after C. Ingram, an English ornithologist) is one of five large elapid species which occur mainly on inland flood plains with deeply fissured soils in which they shelter during the heat of the day. It grows to a length of 170 cm, occurs in five distinct colours, and has a highly flexible head which can squeeze into extremely narrow spaces and yet grip quite large prey. It feeds on small mammals and is active in the cooler early morning and late afternoon and thought to be very reluctant to attack humans 9 • Captive specimens of P. ingrami are considered to be non-aggressive and it was believed that the snake mistook the snake handler's finger for food. The rapid onset of symptoms may have been accelerated by the early activity of the patient and the failure to immediately apply a compression bandage and immobilise the limb. Envenomation is common in snake handlers lo and herpetologists ll . Although sucking the bite site is not recommended 12, many herpetoiogists consider this a worthwhile manoeuvre, particularly where the snake species is already known.
Brown snake envenomation is characterised by DIC, muscle paralysis and cardiovascular depression. Less common complications include thrombocytopenia, renal failure and conduction defects l3ls . The cardiovascular and haematological effects of whole venom from three Pseudonaja species (P. textilis, P. affinis and P. nuchalis) have been studied in mechanically ventilated dogs"s. Intravenous envenomation causes a decrease in cardiac output within five minutes and rapid onset of thrombocytopenia and DIe. Brown snakes have many clinically significant toxins with a wide range of effects which may occur in any combination ls and possibly vary according to the season l6 . DIC is primarily caused by prothrombin activation, but venom also causes human platelets to aggregate, possibly contributing to DIC17. Heparin is not recommended for the treatment of established human envenomation l8 . Muscle paralysis is caused by pre-and postsynaptic neurotoxins 7. Cardiovascular depression is probably secondary to DIC 9 , but a direct toxic effect has not been excluded. Myolysis appears to be uncommon following brown snake envenomation 7 • The envenomation profiles of P. textilis, affinis and nuchalis are broadly similar although it has been suggested that P. affinis is more strongly neurotoxic 7 • Renal failure has been reported following P. nuchalis envenomation 20 • The predominant features of P. ingrami envenomation, as demonstrated by the current case, were early onset of neurological symptoms, severe DIC with mild haemolysis, thrombocytopenia and renal impairment. Although it is possible that the early symptoms were due to a cardiotoxic or neurotoxic effect, cardiovascular instability and weakness were not prominent features of the envenomation. Steroids have been used to prevent serum sickness following snake envenomation, though their efficacy is unknown 21. Although the patient did not develop any abnormal reaction following the first dose of antivenom, repeat doses of adrenaline were given in view of previous exposure to antivenom. Unfortunately, due to a clerical error, the patient also received repeat doses of promethazine which resulted in a dystonic reaction. Two 50 mg doses would have sufficed over the time frame of antivenom administration.
In summary, we present a case of human envenomation by Ingram's Brown Snake which confirms previous beliefs that P. ingrami is highly venomous. The profile of toxic effects appears to be in keeping with those from other highly dangerous brown snakes. Brown snake anti venom provided effective management.
